Inventor
Marcus Kelly
Inventor
New York, NY, US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
PatentTitleYear
10,738,130Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof202010,738,124Anti-EGFRvIII antibodies and uses thereof202010,736,976Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging202010,683,354Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells202010,106,616Antagonist antibodies to human prolactin receptor (PRLR)201810,047,160Anti-EGFRvIII antibodies and uses thereof20189,688,764'Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies'20179,545,451'Anti-PRLR antibodies and methods for killing PRLR-expressing cells'20179,475,875'Anti-EGFRvIII antibodies and uses thereof'20169,302,015'Anti-PRLR antibodies and methods for killing PRLR-expressing cells'2016Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2016–2020Patents assigned to REGENERON PHARMA (10)· patent assignee history
2016–2020Based in New York, NY, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| REGENERON PHARMA | 10 | 2016–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| New York, New York, US | 10 | 2016–2020 |